Log in to save to my catalogue

Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of...

Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f241fe1ca73a4d57a683434142928c6c

Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer’s Disease

About this item

Full title

Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer’s Disease

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2024-11, Vol.29 (22), p.5357

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

As some previously reported studies have proven that amodiaquine, in addition to its primary antimalarial activity, also has potential for new applications such as the inhibition of cholinesterases, in our study we focused on the evaluation of the influence of different substituents in the aminoquinoline part of the amodiaquine structure on the inh...

Alternative Titles

Full title

Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer’s Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f241fe1ca73a4d57a683434142928c6c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f241fe1ca73a4d57a683434142928c6c

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules29225357

How to access this item